Glycine-conjugated porphyrin fluorescent probe with iRGD for live cell imaging

Qian Zhang Xue Dong Kun-Peng Wang Ting-Ting Zhu Feng-Nan Sun Shu-Xian Meng Ya-Qing Feng

Citation:  Zhang Qian, Dong Xue, Wang Kun-Peng, Zhu Ting-Ting, Sun Feng-Nan, Meng Shu-Xian, Feng Ya-Qing. Glycine-conjugated porphyrin fluorescent probe with iRGD for live cell imaging[J]. Chinese Chemical Letters, 2017, 28(4): 777-781. doi: 10.1016/j.cclet.2017.03.001 shu

Glycine-conjugated porphyrin fluorescent probe with iRGD for live cell imaging

English

  • Tumor is a great life threat to human. The past decade we have witnessed the burgeoning of optical imaging and its wide applications for biomedicines such as genomics, proteomics, cell biology, and drug discovery [1].

    As we all know, early-stage tumor has been detected by the invention of kinds of probes, especially the invention of radiationless fluorescence probes [2, 3]. Fluorescence probe which can be used to improve tumor early detection is still a popular topic among related experts and researchers. Recently, the near-infrared (NIR) fluorescence probes are increasingly popular in biological imaging and sensing for the reason that longwavelength (650–900 nm) excitation and emission have the advantages of minimum photodamage to biological samples, deep tissue penetration, and minimum interference from background to fluorescence by biomolecules in the living systems [46]. However, the development of NIR fluorescence probes has some troubles, such as photostabilities and fluorescence quantum yields of probes, targeting of tumors. Up to now, the common NIR fluorophores only have cyanine dyes, such as Cy5 and Cy7 [7, 8].

    Porphyrins [9], due to the unique properties of photophysical and photochemical, have a special relevance to photodiagnosis (PD) and in photodynamic therapy (PDT) of oncological and non oncological diseases [10]. Moreover, we used porphyrins as fluorescence probes because they are relatively stable and have good photostability [11].

    Tumor-penetrating internalizing RGD peptide (iRGD) is known to have a relatively high and specific affinity for αvβ3 - integrin receptor [1214], which is increased vascular and tissue permeability in a tumor-specific and neuropilin-1-depenendent manner, allowing co-administered drugs to penetrate into extravascular tumor tissue. The CendR motif, a class of cell and tissue-penetrating peptides with a specific R-x-x-R carboxylterminal motif, is not active unless it occupies a C-terminal position in the peptide after the cleavage, recognizing neuropillin-1(the receptor for the CendR peptides) and facilitating the penetration into the tumor of iRGD and co-administered drugs [15].

    In this study, the iRGD [16], which having tumor-penetrating ability and good cell membrane permeability, was used to improve the permeability of cell membrane firstly, and then the fluorescent probe TPP-glycine was apt to enter into cells.

    The synthetic process of TPP-glycine was shown in Scheme 1. The TPP and TPP-glycine were identified by analyzing the absorption of hydrogen in Fig. 1.

    Scheme 1

    图 Scheme 1  Synthesis of the probe.
    Scheme 1.  Synthesis of the probe.

    图 1

    图 1  1H NMR spectra of TPP (left) and TPP-glycine (right).
    Figure 1.  1H NMR spectra of TPP (left) and TPP-glycine (right).

    1H NMR (400MHz, CDCl3): δ 8.91 (6H), 8.83 (d, 2H, J=4.7Hz), 8.48 (d, 2H, J=8.0Hz), 8.35 (d, 2H, J=8.0Hz), 8.26 (3H), 8.25 (3H), 7.85–7.80 (m, 6H), 7.80–7.76 (m, 4H), 4.15 (s, 3H), -2.73 (s, 2H). MALDI-TOF MS C46H32N4O2 calcd. for 672.25, found 672.21.

    1H NMR (400MHz, CDCl3): δ 8.91–8.74 (m, 8H), 8.34–8.17 (m, 10H, ArH), 7.83–7.70 (m, 9H, ArH), 4.44 (d, 2H, CH2), 3.89 (s, 3H, CH3), -2.78 (s, 2H). MALDI-TOF MS C48H35N5O3 calcd. for 729.27, found 730.26.

    The absorption, emission intensity and fluorescence quantum yield results were displayed in Fig. 2 and Table 1, respectively.

    图 2

    图 2  Absorption (a) and fluorescence (b) spectra of TPP, TPP-COOH, TPP-glycine in CH2Cl2 solution (3 × 10-6 mol/L).
    Figure 2.  Absorption (a) and fluorescence (b) spectra of TPP, TPP-COOH, TPP-glycine in CH2Cl2 solution (3 × 10-6 mol/L).

    表 1

    表 1  Absorption wavelength, B band-excited fluorescence maxima of the porphyrins, fluorescence quantum yield and fluorescence lifetime in CH2Cl2 solution.
    Table 1.  Absorption wavelength, B band-excited fluorescence maxima of the porphyrins, fluorescence quantum yield and fluorescence lifetime in CH2Cl2 solution.
    下载: 导出CSV

    These results indicate that introduced carboxyl group and further glycine methyl ester has no significant influence on the optical properties of the porphyrin core.

    As shown in Fig. 3, the aggregation degree of TPP and TPPglycine had no obvious change. However, aggregation degree of TPP-glycine D4 is much strongerthanTPP D2 when interactedwith iRGD[17]. Therefore, iRGD has the function which promotes probes to penetrate GLC-82 cytomembrane easily. The results were identical with those reported in literature [18].

    图 3

    图 3  Fluorescence microscope images of living GLC-82 cells. (B1) GLC-82 cells; (B2) GLC-82 cells were incubated with TPP for 1 h; (B3) GLC-82 cells were incubated with TPP-COOH for 1 h; (B4) GLC-82 cells were incubated with TPP-glycine for 1 h. (D1–D4): GLC-82 cells were pre-incubated with iRGD for 1 h, and then treated with the probe (D1-none, D2-TPP, D3-TPP-COOH, D4-TPP-glycine) for 1 h. For DAPI and BODIPY, the excitation wavelength is set as 488 nm and 633 nm, respectively.
    Figure 3.  Fluorescence microscope images of living GLC-82 cells. (B1) GLC-82 cells; (B2) GLC-82 cells were incubated with TPP for 1 h; (B3) GLC-82 cells were incubated with TPP-COOH for 1 h; (B4) GLC-82 cells were incubated with TPP-glycine for 1 h. (D1–D4): GLC-82 cells were pre-incubated with iRGD for 1 h, and then treated with the probe (D1-none, D2-TPP, D3-TPP-COOH, D4-TPP-glycine) for 1 h. For DAPI and BODIPY, the excitation wavelength is set as 488 nm and 633 nm, respectively.

    MTT assay [19] can be used to detect the toxicity of cells. The results in Fig. 4ac showed that the cell viability decreased with the increase of concentration of probe. Compared with TPP-glycine and TPP, the toxicity of TPP-COOH is obviously bigger than the others when the concentration of probes is higher than 5 μmol/L. The date has showed that added iRGD has no significant influence on cells. In a practical application, the safe concentration of probes for cells are lesser than 1 μmol/L. From Fig. 4, the values of cell viability are greater than 90% when the concentration of probes is lesser than 1 μmol/L. Therefore, theprobescan be applied todetect tumor cells.

    图 4

    图 4  The MTT assay results of TPP (a), TPP-COOH (b) and TPP-glycine (c).
    Figure 4.  The MTT assay results of TPP (a), TPP-COOH (b) and TPP-glycine (c).

    In this paper, TPP-glycine was synthesized and characterized by UV–spectrophotometer, fluorescence spectrophotometer, fluorescence microscope, and MTT assay. Experimental results showed that the porphyrins modified with glycine methyl ester had a good affinity with GLC-82 cells than other porphyrins when interacted with iRGD. And it also indicated that iRGD can penetrate GLC-82 cell membranes contribute to enter into cells of fluorescent probe TPP-glycine.

    Silica gel (200–300 mesh, 300–400mesh), Liquid NMR (Bruker AVANCE Ⅲ 400M), MALDI-TOF-MS (Bruker Autoflex tof/tof Ⅲ), UV–vis spectrophotometer (Shimadzu UV-1800), Fluorescence spectrophotometer (Varian Cary Eclipse), Transient Fluorescence (Horiba JY Fluorolog-3), Flow Cytometry (FACScalibur).

    Pyrrole(AR, Nanjin Tianzun Chemical Ltd.), methyl p-formylbenzoate (AR, Nanjin Tianzun Chemical Ltd.), trifluoroacetate (AR, Northern Chemical Reagent Chemical Ltd), benzaldehyde (AR, Tianjin Guangfu Chemical Limited Corporation), DMF (AR, Tianjin Guangfu Chemical Ltd.), iRGD (96%, GL Biochem Ltd.).

    A solution of phenyl pyrrolidine (146.2 mg, 1 mmol), methyl 4-formylbenzoate (82.1 mg, 0.5 mmol), and aromatic aldehyde (0.5 mmol) in CH2Cl2 (100 mL) were added F3CCOOH (0.6 mmol, 44 μL). The mixture was stirred in the dark for 3 h and then DDQ (0.9 mmol, 200 mg) was added. After the solution was further stirred at room temperature for 1 h. NaHCO3 (106 mg, 1 mmol) was added and the solvent was removed from reduced pressure. The product was isolated by column chromatography (silicagel) using CH2Cl2/hexane = 1/2 as eluent. Next, A mixture of TPP (0.1 mmol) and KOH (2 mmol) in THF (5 mL), EtOH (1 mL) and water (1 mL) was refluxed for 2 h. After the solution was cooled to room temperature, the residue was dissolved in water (50 mL) and acidified to pH 3 with 1 mol/L HCl solution. CH2Cl2 was added and the organic layer was collected. The solvent was removed in vacuo. Recrystallization from CH2Cl2 gave TPP-COOH (0.95 mmol, 95%) C45H30N4O2 calcd. for 658.24, found 659.20.

    The EDC·HCl (1.53 mg, 8 mmol) and NHS (1.15 mg, 10 mmol) were added to the solution of TPP-COOH (2.63 mg, 5 mmol) in anhydrous DMF (2 mL). The mixture was stirred at room temperature for 12 h. And then glycine (2.4 mg, 4 equiv.) was dissolved in anhydrous DMF (2 mL) and a large excess of K2CO3 was added. The reaction was kept for 12 h at room temperature and then poured into CH2Cl2 (30 mL), washed with water. The product was collected by filtration and purified by flash chromatography (CH2Cl2) to obtain the final TPP-glycine as a solid.

    The concentration 3 × 10-6 mol/L of TPP, TPP-COOH, or TPPglycine were prepared which the porphyrins dissolved in CH2Cl2 solution. And then the values of UV absorption and emission intensity were tested by UV–spectrophotometer and fluorescence spectrophotometer.

    The GLC-82 cells were cultured with RPMI 1640 medium in the incubator (37 ℃, 5% CO2). The cultured cells were washed by PBS, and added trypsin. Then put them into the 15 mL centrifuge tube. Finally, centrifuging (500 rpm, 5 min), making suspension of cells and counting cells.

    Cover glasses were plated into 48-multiwell plate, and then a density of 5 × 104 cells each well were plated and grown on cover glasses, cultured 24 h in the incubator (37 ℃, 5% CO2). After 24 h, the iRGD (2 μmol/L) was plated in single well and cultured 1 h firstly. Next 2 μmol/L TPP, TPP-COOH, TPP-glycine was plated in wells which including iRGD and no iRGD, respectively and cultured 1 h. Then the cells were washed by PBS three times and added paraformaldehyde to fix cells for room temperature 5 min and washed by PBS three times again. And then cellular nuclei were stained by DAPI for room temperature 5 min. The DAPI was washed by PBS three times. Finally, the cover glasses were taken out from wells, added anti-fade fluorescence mounting medium and fixed on the glass slides with transparent nail polish. The made-samples were measured with Confocal Microscope (Ultra View Vox).

    Cell viability measurements were performed by MTT analysis. Cells were plated at a density of 5 × 104 cells each well into 96-multiwell plate for 24 h in the incubator (37 ℃, 5% CO2). Making up 2 μmol/L iRGD and different concentration TPP, TPP-COOH, TPP–glycine. Concentrations were as follows: 10 μmol/L, 5 μmol/L, 1 μmol/L, 10 nm, 100 nm. First, adding 100 μL iRGD into cells and cultured for 1 h. Next, different concentration TPP, TPP-COOH, TPP-glycine were added to the wells which including iRGD and wells without iRGD, respectively. After 48 h, 10 μL MTT (5 μg/mL) was added into every single well and incubation was continued for 4 h at 37 ℃. Then, 90 μL DMSO was added to single wells to dissolve the blue formazan in the live cells. Finally, the value of OD were measured at 490 nm using a microplate reader (Thermo Scientific).

    This work is supported by National Natural Science Foundation of China (No. 21076147). We are grateful to Prof. H. Huang and Prof. L. Yang for providing GLC-82 cells and some support.

    1. [1]

      Tanaka S., Kizaka-Kondoh S.. Development of fluorescent in vivo imaging probes for cancers[J]. Gan to Kagaku Ryoho, 2008, 35:  1272-1276.

    2. [2]

      Zhao H.Y., Li Y.M., Gong T.J., Guo Q.X.. A highly selective and easy-to-synthesize Zn(Ⅱ) fluorescent probe based on 6-methoxyquinolin[J]. Chin.Chem.Lett., 2011, 22:  1013-1016. doi: 10.1016/j.cclet.2011.03.007

    3. [3]

      Gao Y., Li J.L., Shi Z.. Synthesis and application of rhodamine-based fluorescent probe dyes with spacer linker arm[J]. Chin.Chem.Lett., 2007, 18:  667-669. doi: 10.1016/j.cclet.2007.04.007

    4. [4]

      Sun C.L., Cai J., Chen J.Q.. The synthesis of a novel near-infrared fluorescent probe and its application in imaging of living cells[J]. Appl.Biochem. Biotechnol., 2015, 175:  1644-1650. doi: 10.1007/s12010-014-1398-9

    5. [5]

      Shao F.W., Weissleder R., Hilderbrand S.A.. Monofunctional carbocyanine dyes for bio-and bioorthogonal conjugation[J]. Bioconjugate Chem., 2008, 19:  2487-2491. doi: 10.1021/bc800417b

    6. [6]

      Zhang X.F., Xiao Y., Qi J.. Long-wavelength photostable, two-photon excitable bodipy fluorophores readily modifiable for molecular probes[J]. J.Org. Chem., 2013, 78:  9153-9160. doi: 10.1021/jo401379g

    7. [7]

      Li P., Tang B., Xing Y.L.. A near-infrared fluorescent probe for lipid hydroperoxides in living cells[J]. Analyst, 2008, 133:  1409-1415. doi: 10.1039/b802836b

    8. [8]

      Kojima H.. Development of near-infrared fluorescent probes for in vivo imaging[J]. Yakugaku Zasshi., 2008, 128:  1653-1663. doi: 10.1248/yakushi.128.1653

    9. [9]

      Li D.H., Diao J.L., Yu K.G., Zhou C.H.. Synthesis and anticancer activities of porphyrin induced anticancer drugs[J]. Chin.Chem.Lett., 2007, 18:  1331-1334. doi: 10.1016/j.cclet.2007.09.012

    10. [10]

      Choi J., Kim H., Choi Y.. Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer[J]. Quant.Imaging Med.Surg., 2015, 5:  656-664.

    11. [11]

      Giuntini F., Chauhan V.M., Aylott J.W.. Conjugatable water-soluble Pt(Ⅱ) and Pd(Ⅱ)porphyrin complexes:novel nano-and molecular probes for optical oxygen tension measurement in tissue engineering[J]. Photochem.Photobiol. Sci., 2014, 13:  1039-1051. doi: 10.1039/c4pp00026a

    12. [12]

      Amin M., Mansourian M., Koning G.A.. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region[J]. J. Control.Release, 2015, 220:  308-315. doi: 10.1016/j.jconrel.2015.10.039

    13. [13]

      Beer A.J., Schwaiger M.. Imaging of integrin ανβ3 expression[J]. Cancer Metastasis Rev., 2008, 27:  631-644. doi: 10.1007/s10555-008-9158-3

    14. [14]

      Luo M.Y., Chen M.Z., Lee I.. αIbβ3 modeling simulation and design of cyclic RGD peptide[J]. Chin.J.Biotechnol., 2008, 24:  297-301. doi: 10.1016/S1872-2075(08)60015-1

    15. [15]

      Simón-Gracia L., Hunt H., Scodeller P.. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes[J]. Biomaterials, 2016, 104:  247-257. doi: 10.1016/j.biomaterials.2016.07.023

    16. [16]

      Hamilton A.M., Aidoudi-Ahmed S., Sharma S.. Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain[J]. J.Mol.Med., 2015, 93:  991-1001. doi: 10.1007/s00109-015-1279-x

    17. [17]

      Sugahara K.N., Braun G.B., de Mendoza T.H.. Tumor-penetrating iRGD peptide inhibits metastasis[J]. Mol.Cancer Ther., 2015, 14:  120-128.

    18. [18]

      Chilakamarthi U., Kandhadi J., Gunda S.. Synthesis and functional characterization of a fluorescent peptide probe for non invasive imaging of collagen in live tissues[J]. Exp.Cell Res., 2014, 327:  91-101. doi: 10.1016/j.yexcr.2014.05.005

    19. [19]

      Wang L.S., Jiang X.S., Wang H., Cheng S.X., Zhuo R.X.. Preparation and cytotoxicity of novel aliphatic polycarbonate synthesized from dihydroxyacetone[J]. Chin.Chem.Lett., 2005, 16:  572-574.

  • Scheme 1  Synthesis of the probe.

    Figure 1  1H NMR spectra of TPP (left) and TPP-glycine (right).

    Figure 2  Absorption (a) and fluorescence (b) spectra of TPP, TPP-COOH, TPP-glycine in CH2Cl2 solution (3 × 10-6 mol/L).

    Figure 3  Fluorescence microscope images of living GLC-82 cells. (B1) GLC-82 cells; (B2) GLC-82 cells were incubated with TPP for 1 h; (B3) GLC-82 cells were incubated with TPP-COOH for 1 h; (B4) GLC-82 cells were incubated with TPP-glycine for 1 h. (D1–D4): GLC-82 cells were pre-incubated with iRGD for 1 h, and then treated with the probe (D1-none, D2-TPP, D3-TPP-COOH, D4-TPP-glycine) for 1 h. For DAPI and BODIPY, the excitation wavelength is set as 488 nm and 633 nm, respectively.

    Figure 4  The MTT assay results of TPP (a), TPP-COOH (b) and TPP-glycine (c).

    Table 1.  Absorption wavelength, B band-excited fluorescence maxima of the porphyrins, fluorescence quantum yield and fluorescence lifetime in CH2Cl2 solution.

    下载: 导出CSV
  • 加载中
计量
  • PDF下载量:  2
  • 文章访问数:  598
  • HTML全文浏览量:  31
文章相关
  • 发布日期:  2017-04-22
  • 收稿日期:  2017-01-03
  • 接受日期:  2017-03-02
  • 修回日期:  2017-01-13
  • 网络出版日期:  2017-04-04
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章